Guo Xiang-Yun

Guo Xiang-Yun

Auto-generated profile, based on publicly available information

Guo Xiang-Yun

Department of Pharmacology, School of Basic Medical Sciences (Q.C., Y.L., J.W., Y.G., X.G., J.L., H. Lv, M.L., X.W., F.Y.), Shandong University, Jinan, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2024 in Circulation Research
Verified
Journal Article
Closed access
QCQingqing Chu
Qingqing Chu
YLYujia Li
Yujia Li
JWJichao Wu
Jichao Wu
YGYanjiao Gao
Yanjiao Gao
XGXiangyun Guo
Xiangyun Guo
FYFan Yi
Fan Yi
BACKGROUND: Despite endothelial dysfunction being an initial step in the development of hypertension and associated cardiovascular/renal injuries, effective therapeutic strategies to prevent endothelial dysfunction are still lacking. GPR183 (G protein-coupled receptor 183), a recently identified G protein-coupled receptor for oxysterols and hydroxylated metabolites of cholesterol, has pleiotropic roles in lipid metabolism and immune responses. However, the role of GPR183 in the regulation of endothelial function remains unknown. METHODS: Endothelial-specific GPR183 knockout mice were generated and used to examine the role of GPR183 in endothelial senescence by establishing 2 independent hypertension models: desoxycorticosterone acetate/salt-induced and Ang II (angiotensin II)–induced hypertensive mice. Echocardiography, transmission electron microscopy, blood pressure measurement, vasorelaxation response experiments, flow cytometry analysis, and chromatin immunoprecipitation analysis were performed in this study. RESULTS: Endothelial GPR183 was significantly induced in hypertensive mice, which was further confirmed in renal biopsies from subjects with hypertensive nephropathy. Endothelial-specific deficiency of GPR183 markedly alleviated cardiovascular and renal injuries in hypertensive mice. Moreover, we found that GPR183 regulated endothelial senescence in both hypertensive mice and aged mice. Mechanistically, GPR183 disrupted circadian signaling by inhibiting PER1 (period circadian regulator 1) expression, thereby facilitating endothelial senescence and dysfunction through the cAMP (cyclic adenosine monophosphate)/PKA (protein kinase A)/CREB (cAMP-response element binding protein) signaling pathway. Importantly, pharmacological inhibition of the oxysterol-GPR183 axis by NIBR189 or clotrimazole ameliorated endothelial senescence and cardiovascular/renal injuries in hypertensive mice. CONCLUSIONS: This study discovers a previously unrecognized role of GPR183 in promoting endothelial senescence. Pharmacological targeting of GPR183 may be an innovative therapeutic strategy for hypertension and its associated complications.

1 January 2014 in Acta Physico-Chimica Sinica
Verified
Journal Article
Open access
PDF file
DLDong Li-Li
Dong Li-Li
YWYingyong Wang
Yingyong Wang
TXTong Xi-Li
Tong Xi-Li
JGJin Guo-Qiang
Jin Guo-Qiang
GXGuo Xiang-Yun
Guo Xiang-Yun

12 February 2024 in The FASEB Journal
Verified
Journal Article
Closed access
PGPing Gao
Ping Gao
JZJinghan Zhu
Jinghan Zhu
GXGuo Xiangyun
Guo Xiangyun
JLJing Li
Jing Li
JWJichao Wu
Jichao Wu